NextCell Pharma AB (NXTCL)

Stockholm

Currency in SEK

1.59

+0.03(+1.93%)

Closed·06/02

Fair Value

Unlock Value

Day's Range

1.50

1.60

52 wk Range

0.63

3.84

NXTCL Income Statement

Featured here, the Income Statement (earnings report) for NextCell Pharma AB, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/08

2017

31/08

2018

31/08

2019

31/08

2020

31/08

2021

31/08

2022

31/08

2023

31/08

2024

31/08

2025

31/08

Total Revenues

aa.aa

4.46

6.23

13.96

11.28

11.06

Total Revenues Growth

aa.aa

+6.94%

+39.82%

+124.03%

-19.18%

-1.9%

Cost Of Revenues

aa.aa

9.94

8.72

15.22

9.4

Gross Profit

aa.aa

-5.48

-2.49

2.96

-3.94

1.67

Gross Profit Growth

aa.aa

-110.96%

+54.53%

+218.59%

-233.4%

+142.27%

Gross Profit Margin %

aa.aa

-123.08%

-40.03%

21.19%

-34.97%

15.07%

Other Operating Expenses, Total

aa.aa

19.34

32.53

43.96

39.23

37.55

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+28.04%	+68.22%	+35.13%	-10.76%	-4.26%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	18.84	31.85	43.47	38.22	34.9
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.06	0.22	0.04	0.04	0.14

Operating Income

aa.aa

-24.82

-35.02

-41

-43.17

-35.89

Operating Income Growth

aa.aa

-40.21%

-41.11%

-17.07%

-5.29%

+16.87%

EBIT Margin %

aa.aa

-557.14%

-562.26%

-293.81%

-382.79%

-324.35%

Net Interest Expenses

aa.aa

0.26

0.47

1.19

1.21

0.74

Net Interest Expenses Growth

aa.aa

+1,119.5%

+77.69%

+153.53%

+1.83%

-38.6%

Interest Expense, Total

aa.aa

-0.01

-0

Interest And Investment Income

aa.aa

0.27

0.48

1.19

1.21

0.75

Other Non Operating Expenses, Total

aa.aa

EBT, Excl. Unusual Items

aa.aa

-24.56

-34.55

-39.81

-41.96

-35.14

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-24.56

-34.55

-39.81

-41.96

-35.14

EBT, Incl. Unusual Items Growth

aa.aa

-38.89%

-40.71%

-15.21%

-5.4%

+16.25%

EBT, Incl. Unusual Items Margin

aa.aa

-551.21%

-554.72%

-285.28%

-372.04%

-317.62%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-24.56

-34.55

-39.81

-41.96

-35.14

Minority Interest

aa.aa

Net Income

aa.aa

-24.56

-34.55

-39.81

-41.96

-35.14

Net Income Growth

aa.aa

-38.89%

-40.71%

-15.21%

-5.4%

+16.25%

Net Income Margin %

aa.aa

-551.21%

-554.72%

-285.28%

-372.04%

-317.62%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-24.56

-34.55

-39.81

-41.96

-35.14

Basic EPS - Continuing Operations

aa.aa

-0.81

-1.01

-1.16

-1.03

-0.46

Basic EPS - Continuing Operations Growth

aa.aa

+9.28%

-24.47%

-15.21%

+11.22%

+55.26%

Diluted EPS - Continuing Operations

aa.aa

-0.81

-1.01

-1.16

-1.03

-0.46

Diluted EPS - Continuing Operations Growth

aa.aa

+9.28%

-24.47%

-15.21%

+11.22%

+55.26%

Basic Weighted Average Shares Outstanding

aa.aa

30.41

34.38

40.81

76.41

Diluted Weighted Average Shares Outstanding

aa.aa

30.41

34.38

40.81

76.41

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-24.38

-34.57

-40.55

-42.2

-33.37

EBITDA Growth

aa.aa

-40.91%

-41.76%

-17.32%

-4.05%

+20.91%

EBITDA Margin %

aa.aa

-547.33%

-554.92%

-290.6%

-374.15%

-301.61%

EBIT

aa.aa

-24.82

-35.02

-41

-43.17

-35.89

* In Millions of SEK (except for per share items)

FAQ

What was NextCell Pharma AB’s revenue at year end?

At the end of the last reported fiscal year, NextCell Pharma AB (NXTCL) recorded total revenue of 11.06.

How much revenue did NextCell Pharma AB report in the most recent quarter?

In its most recent quarterly earnings report, NextCell Pharma AB posted revenue of 2.52.

What was NextCell Pharma AB’s net income for the year?

For the full year, NextCell Pharma AB reported net income of -35.14.

How much net income did NextCell Pharma AB post in the last quarter?

In the most recent quarter, NextCell Pharma AB (NXTCL) posted net income of -8.63.

What was NextCell Pharma AB’s gross profit for the year?

Gross profit for the year was reported at 1.67.

How much gross profit did NextCell Pharma AB generate last quarter?

NextCell Pharma AB recorded gross profit of 0.32 in its latest quarterly report.

What was NextCell Pharma AB’s annual operating income?

For the full year, NextCell Pharma AB (NXTCL) reported operating income of -35.89.

What was NextCell Pharma AB’s operating income last quarter?

Quarterly operating income was -8.79.

What was NextCell Pharma AB’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -8.18.

What was the quarter-over-quarter change in EBITDA for NextCell Pharma AB?

EBITDA changed by 16.02% compared to the last quarter.

What is NextCell Pharma AB’s most recent gross profit margin?

The latest reported gross profit margin for NextCell Pharma AB (NXTCL) is 12.62%.

What is NextCell Pharma AB’s most recent net income margin?

Net income margin based on recent financials is -342.26%.

What is NextCell Pharma AB’s most recent EBIT margin?

NextCell Pharma AB reported an EBIT margin of -348.65% based on current figures.

How did NextCell Pharma AB’s revenue change compared to the previous quarter?

Revenue changed by 11.51% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for NextCell Pharma AB?

In the latest quarter 2026, gross profit changed by 114.55% from the previous quarter.

S&P/TSX

32,470.98

+476.38

+1.49%

S&P/TSX 60

1,882.66

+22.09

+1.19%

US 30

50,177.60

+61.9

+0.12%

US 500

6,935.40

+3.1

+0.05%

S&P 500 VIX

17.76

-4.01

-18.42%

DAX

24,721.46

+230.40

+0.94%

Dollar Index

97.36

-0.146

-0.15%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	22.83	-10.12%	19.62M
Enbridge	68.74	-0.58%	12.76M
Toronto Dominion Bank	131.99	+1.40%	8.24M
Canadian Natural	53.40	+2.89%	7.94M
Bank of Nova Scotia	104.30	+1.07%	3.99M
Bank of Montreal	193.48	+0.98%	2.70M
RBC	232.72	+0.69%	2.65M

Name	Last	Chg. %	Vol.
Grounded People Apparel	0.100	+1,900.00%	2.50K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Verses AI	2.60	+188.89%	109.79K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Yumy Bear Goods	0.02	+100.00%	1.00K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Planet Based Foods Global	0.01	-81.82%	35.00K
TripSitter Clinic	0.15	-69.39%	1.50K
Kovo Healthtech	0.02	-66.67%	240.01K
Molecule Holdings	0.005	-50.00%	20.11K
Global Cannabis Apps	0.010	-50.00%	220.00K
MyndTec	0.01	-50.00%	25.00K

Trending Stocks

Name	Last	Chg. %	Vol.
ARC Resources	22.83	-10.12%	19.62M
Bitfarms	2.92	+25.32%	9.92M
TELUS	19.32	-1.23%	7.26M
Thomson Reuters	120.18	-0.64%	1.43M
Toronto Dominion Bank	131.99	+1.40%	8.24M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa Aaa	88.99	+63.76%	145.73
Aaaaa A	8.03	+53.33%	12.31
Aa Aaaa A	34.26	+52.56%	52.27
Aaa Aaaaaaaa Aa	21.38	+51.22%	32.33
Aa Aa	61.53	+49.40%	91.93
Aaaaaaaaaaaaaaaaaaa	17.95	+49.07%	26.76
Aaaaaaaaaaaaaaaa	112.92	+41.30%	159.56

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa Aaa	88.99	+63.76%	145.73
Aaaaa A	8.03	+53.33%	12.31
Aa Aaaa A	34.26	+52.56%	52.27
Aaa Aaaaaaaa Aa	21.38	+51.22%	32.33
Aa Aa	61.53	+49.40%	91.93
Aaaaaaaaaaaaaaaaaaa	17.95	+49.07%	26.76
Aaaaaaaaaaaaaaaa	112.92	+41.30%	159.56

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

NextCell Pharma AB (NXTCL)

NXTCL Income Statement

FAQ

What was NextCell Pharma AB’s revenue at year end?

How much revenue did NextCell Pharma AB report in the most recent quarter?

What was NextCell Pharma AB’s net income for the year?

How much net income did NextCell Pharma AB post in the last quarter?

What was NextCell Pharma AB’s gross profit for the year?

How much gross profit did NextCell Pharma AB generate last quarter?

What was NextCell Pharma AB’s annual operating income?

What was NextCell Pharma AB’s operating income last quarter?

What was NextCell Pharma AB’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for NextCell Pharma AB?

What is NextCell Pharma AB’s most recent gross profit margin?

What is NextCell Pharma AB’s most recent net income margin?

What is NextCell Pharma AB’s most recent EBIT margin?

How did NextCell Pharma AB’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for NextCell Pharma AB?

Trending Stocks